Key statistics
On Thursday, Veracyte Inc (VCYT:NMQ) closed at 38.94, -6.01% below its 52-week high of 41.43, set on Nov 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.38 |
---|---|
High | 39.81 |
Low | 38.73 |
Bid | 37.85 |
Offer | 47.19 |
Previous close | 39.20 |
Average volume | 939.47k |
---|---|
Shares outstanding | 77.50m |
Free float | 76.89m |
P/E (TTM) | -- |
Market cap | 3.02bn USD |
EPS (TTM) | -0.1445 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Veracyte Announces Third Quarter 2024 Financial Results
- Veracyte to Participate in Upcoming Investor Conferences
- Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
- New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
- New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
- Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
More ▼